Geis, Nicolas <br/><br/>
Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.  [electronic resource] 

 -  Current cancer drug targets  Dec 2010 
 - 922-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5576 
<br/><br/><label>Standard No.: </label>10.2174/156800910793357952  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD55 Antigens--chemistry<br/>CD59 Antigens--chemistry<br/>Complement Activation--genetics<br/>Flow Cytometry<br/>Humans<br/>Membrane Cofactor Protein--antagonists & inhibitors<br/>Neoplasms--genetics<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>RNA, Small Interfering--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Tumor Cells, Cultured